The Mevion S250 proton therapy system has become the first proton therapy system to receive a medical device license from Health Canada, the federal department responsible for public health, and is now approved to be installed at cancer facilities across the country.

At the 2015 annual meeting of the Healthcare Information and Management Systems Society (HIMSS), Carestream will demostrate its flexible Clinical Collaboration Platform, which now offers a new module to tag clinical data files and bring them into the workflow. These new capabilities build upon Carestream’s fully featured vendor neutral archive (VNA) architecture.

One of the hottest topics in current Alzheimer’s research is brain scans that visualize tau pathology in living people. With the advent of positron emission tomography (PET) tracers that label neurofibrillary tangles, researchers are now able to "see" and quantify both hallmark pathologies defined by Alois Alzheimer in 1906: amyloid plaques and tau tangles. Tau tracers dominated the agenda when 340 researchers convened in Miami Beach, Florida, recently to debate the current edge in human amyloid imaging.